[ad_1]
On the night of the 12th, the advisory committee for the introduction of a new vaccine against coronavirus infection (Corona 19) will be held for the first time. This committee will discuss the criteria for purchasing COVID-19.
Tae-ho Yoon, head of the Accident Control Headquarters of the Ministry of Health and Welfare, said at a press conference on the morning of the 12th: “A committee to buy vaccines is likely to be held tonight.”
As the interim results of clinical trials that the vaccine, which is jointly developed by the American pharmaceutical company Pfizer and the German Bioentech, has the effect of preventing COVID-19 is greater than 90%, the future launch schedule and the purchase / supply procedure are focused.
In July, the United States signed a vaccine delivery contract with these pharmaceutical companies worth $ 1.95 billion (about 2.3 trillion won). Upon completion of vaccine development, if safety is demonstrated, 100 million doses will be delivered first. “The vaccine is not yet in the production stage, but safety is the most important because it is the first vaccine to be inoculated,” he said. “Korea regards safety as the top priority as a vaccine purchasing standard.” He said: “(Today) the committee is in contact and negotiating with several companies, and a procedure will be carried out to determine the company considering the safety and efficacy of the vaccine,” he said. “Currently, we are in consultation with several pharmaceutical companies, including Pfizer. I know that Pfizer is doing well too.”
He added: “It is difficult to say when the contract will be made, but we are trying to make the advance purchase as soon as possible. We are also obtaining useful materials for vaccines through COVAX.”
Sohn Young-rae, head of the Strategic Planning Division, Jung Soo-bon, said: “I will explain the progress tonight or tomorrow (the 13th). I’ll announce it when it’s fixed, “he said.” There is a risk (risk) of this because even the phase 3 test has not been completed and we do not know what the effect and fatality is. “As the situation in each country is urgent, we don’t know where to be successful, so we give money and buy in advance.”
Sohn continued, “The pre-purchase concept itself is not a money-back concept,” he said over and over again, saying, “We are in the process of negotiating the purchase while thinking about how to secure it effectively, although several will move. hundreds of billions of won. “
In September, Korea announced a plan to secure a tiered overseas vaccine for Corona 19. The government decided to insure 30 million vaccines, equivalent to 60% of the total population, through a pre-purchase method, and 10 million people. through the COVAX Facility, a global project for the joint purchase and distribution of vaccines. Through negotiations, it was decided to insure 20 million vaccines.
[세종=뉴시스]Copyright by dongA.com All rights reserved.
